Comprehensive Stock Comparison
Compare Sila Realty Trust, Inc. (SILA) vs Diversified Healthcare Trust (DHC) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | SILA | 5.7% revenue growth vs DHC's 2.8% |
| Quality / Margins | SILA | 16.8% net margin vs DHC's -18.6% |
| Stability / Safety | SILA | Beta 0.48 vs DHC's 0.75 |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | DHC | +140.3% vs SILA's +7.5% |
| Efficiency (ROA) | SILA | 1.6% ROA vs DHC's -6.6%, ROIC 3.0% vs -0.9% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Sila Realty Trust is a healthcare-focused real estate investment trust that acquires and leases medical facilities across the United States. It generates revenue primarily through long-term net leases—where tenants pay rent plus property expenses—with healthcare operators accounting for nearly all its income. The company's competitive advantage lies in its specialized focus on healthcare real estate, which provides recession-resistant cash flows due to the essential nature of medical services.
Diversified Healthcare Trust is a real estate investment trust that owns and operates healthcare-related properties including medical office buildings, senior living communities, and life science facilities. It generates revenue primarily through property rental income — with medical office properties contributing roughly 60% of net operating income and senior living communities about 40% — along with management fees from its operating partner. The company's competitive advantage lies in its specialized healthcare real estate portfolio and its long-term management relationship with The RMR Group, which provides operational expertise in the healthcare property sector.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
DHC leads in 3 of 6 categories (Valuation Metrics, Total Returns). SILA leads in 2 (Financial Metrics, Profitability & Efficiency). 1 tied.
Financial Metrics (TTM)
DHC is the larger business by revenue, generating $1.5B annually — 7.8x SILA's $198M. SILA is the more profitable business, keeping 16.8% of every revenue dollar as net income compared to DHC's -18.6%. On growth, SILA holds the edge at +8.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SILASila Realty Trust… | DHCDiversified Healt… |
|---|---|---|
| RevenueTrailing 12 months | $198M | $1.5B |
| EBITDAEarnings before interest/tax | $145M | $292M |
| Net IncomeAfter-tax profit | $33M | -$286M |
| Free Cash FlowCash after capex | $84M | -$16M |
| Gross MarginGross profit ÷ Revenue | +87.9% | -16.0% |
| Operating MarginEBIT ÷ Revenue | +34.5% | +2.0% |
| Net MarginNet income ÷ Revenue | +16.8% | -18.6% |
| FCF MarginFCF ÷ Revenue | +42.4% | -1.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.9% | -0.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -55.0% | +75.5% |
Valuation Metrics
On an enterprise value basis, DHC's 6.9x EV/EBITDA is more attractive than SILA's 9.7x.
| Metric | SILASila Realty Trust… | DHCDiversified Healt… |
|---|---|---|
| Market CapShares × price | $1.4B | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | 42.88x | -5.68x |
| Forward P/EPrice ÷ next-FY EPS est. | 33.42x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 9.73x | 6.88x |
| Price / SalesMarket cap ÷ Revenue | 7.15x | 1.06x |
| Price / BookPrice ÷ Book value/share | 1.07x | 0.98x |
| Price / FCFMarket cap ÷ FCF | 11.85x | — |
Profitability & Efficiency
SILA delivers a 2.5% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $-17 for DHC. On the Piotroski fundamental quality scale (0–9), SILA scores 6/9 vs DHC's 3/9, reflecting solid financial health.
| Metric | SILASila Realty Trust… | DHCDiversified Healt… |
|---|---|---|
| ROE (TTM)Return on equity | +2.5% | -17.2% |
| ROA (TTM)Return on assets | +1.6% | -6.6% |
| ROICReturn on invested capital | +3.0% | -0.9% |
| ROCEReturn on capital employed | +3.2% | -0.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 |
| Debt / EquityFinancial leverage | — | — |
| Net DebtTotal debt minus cash | -$32M | -$105M |
| Cash & Equiv.Liquid assets | $32M | $105M |
| Total DebtShort + long-term debt | $0 | $0 |
| Interest CoverageEBIT ÷ Interest expense | 1.98x | -0.19x |
Total Returns (with DRIP)
A $10,000 investment in DHC five years ago would be worth $14,904 today (with dividends reinvested), compared to $13,124 for SILA. Over the past 12 months, DHC leads with a +140.3% total return vs SILA's +7.5%. The 3-year compound annual growth rate (CAGR) favors DHC at 91.5% vs SILA's 7.4% — a key indicator of consistent wealth creation.
| Metric | SILASila Realty Trust… | DHCDiversified Healt… |
|---|---|---|
| YTD ReturnYear-to-date | +9.5% | +35.9% |
| 1-Year ReturnPast 12 months | +7.5% | +140.3% |
| 3-Year ReturnCumulative with dividends | +23.9% | +602.0% |
| 5-Year ReturnCumulative with dividends | +31.2% | +49.0% |
| 10-Year ReturnCumulative with dividends | +32.7% | -21.4% |
| CAGR (3Y)Annualised 3-year return | +7.4% | +91.5% |
Risk & Volatility
SILA is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than DHC's 0.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DHC currently trades 98.7% from its 52-week high vs SILA's 93.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SILASila Realty Trust… | DHCDiversified Healt… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.75x |
| 52-Week HighHighest price in past year | $27.50 | $6.85 |
| 52-Week LowLowest price in past year | $21.94 | $2.00 |
| % of 52W HighCurrent price vs 52-week peak | +93.6% | +98.7% |
| RSI (14)Momentum oscillator 0–100 | 63.3 | 68.1 |
| Avg Volume (50D)Average daily shares traded | 289K | 1.4M |
Analyst Outlook
Wall Street rates SILA as "Buy" and DHC as "Hold". Consensus price targets imply -2.8% upside for SILA (target: $25) vs -26.0% for DHC (target: $5).
| Metric | SILASila Realty Trust… | DHCDiversified Healt… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $25.00 | $5.00 |
| # AnalystsCovering analysts | 2 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 2 | 3 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Jun 24 | Feb 26 | Change |
|---|---|---|---|
| Sila Realty Trust, … (SILA) | 100 | 106.52 | +6.5% |
| Diversified Healthc… (DHC) | 100 | 194.02 | +94.0% |
Diversified Healthc… (DHC) returned +49% over 5 years vs Sila Realty Trust, … (SILA)'s +31%. A $10,000 investment in DHC 5 years ago would be worth $14,904 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sila Realty Trust, … (SILA) | $56M | $198M | +250.0% |
| Diversified Healthc… (DHC) | $1.1B | $1.5B | +45.4% |
Sila Realty Trust, Inc.'s revenue grew from $56M (2016) to $198M (2025) — a 14.9% CAGR. Diversified Healthcare Trust's revenue grew from $1.1B (2016) to $1.5B (2025) — a 4.2% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sila Realty Trust, … (SILA) | 20.2% | 16.8% | -17.1% |
| Diversified Healthc… (DHC) | 13.4% | -18.6% | -239.2% |
Sila Realty Trust, Inc.'s net margin went from 20% (2016) to 17% (2025). Diversified Healthcare Trust's net margin went from 13% (2016) to -19% (2025).
Chart 4P/E Ratio History — 3 Years
| Stock | 2017 | 2021 | Change |
|---|---|---|---|
| Diversified Healthc… (DHC) | 30.9 | 4.2 | -86.4% |
Diversified Healthcare Trust has traded in a 4x–31x P/E range over 3 years; current trailing P/E is ~-6x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sila Realty Trust, … (SILA) | 0.67 | 0.6 | -10.4% |
| Diversified Healthc… (DHC) | 0.6 | -1.19 | -298.3% |
Sila Realty Trust, Inc.'s EPS grew from $0.67 (2016) to $0.60 (2025) — a -1% CAGR. Diversified Healthcare Trust's EPS grew from $0.60 (2016) to $-1.19 (2025) — a NaN% CAGR.
Chart 6Free Cash Flow — 5 Years
Sila Realty Trust, Inc. generated $119M FCF in 2025 (+7% vs 2021). Diversified Healthcare Trust generated $-20M FCF in 2025 (+69% vs 2021).
SILA vs DHC: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is SILA or DHC a better buy right now?
Sila Realty Trust, Inc. (SILA) offers the better valuation at 42.9x trailing P/E (33.4x forward), making it the more compelling value choice. Analysts rate Sila Realty Trust, Inc. (SILA) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SILA or DHC?
Over the past 5 years, Diversified Healthcare Trust (DHC) delivered a total return of +49.0%, compared to +31.2% for Sila Realty Trust, Inc. (SILA). A $10,000 investment in DHC five years ago would be worth approximately $15K today (assuming dividends reinvested). Over 10 years, the gap is even starker: SILA returned +32.7% versus DHC's -21.4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SILA or DHC?
By beta (market sensitivity over 5 years), Sila Realty Trust, Inc. (SILA) is the lower-risk stock at 0.48β versus Diversified Healthcare Trust's 0.75β — meaning DHC is approximately 59% more volatile than SILA relative to the S&P 500.
04Which has better profit margins — SILA or DHC?
Sila Realty Trust, Inc. (SILA) is the more profitable company, earning 16.8% net margin versus -18.6% for Diversified Healthcare Trust — meaning it keeps 16.8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SILA leads at 32.9% versus -2.6% for DHC. At the gross margin level — before operating expenses — SILA leads at 87.9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Is SILA or DHC more undervalued right now?
Analyst consensus price targets imply the most upside for SILA: -2.8% to $25.00.
06Which pays a better dividend — SILA or DHC?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is SILA or DHC better for a retirement portfolio?
For long-horizon retirement investors, Sila Realty Trust, Inc. (SILA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.48)). Both have compounded well over 10 years (SILA: +32.7%, DHC: -21.4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between SILA and DHC?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.